STOCK TITAN

Insider sale of 7,800 shares reported by BE (NYSE: BE) in Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer submitted a Form 144 disclosing proposed insider sales of Common stock and recent sales. The filing shows restricted shares listed with 03/15/2025 (4,249 and 1,145 shares) and 04/15/2025 (835 shares). It also records a sale by Maciej Kurzymski of 7,800 shares on 03/16/2026 for $1,184,437.02.

The filing date appears as 05/13/2026. The disclosure is a routine Section 16 resale notice reporting planned sales and a recent disposition; cash‑flow treatment and planned sale mechanics are not detailed in the provided excerpt.

Positive

  • None.

Negative

  • None.

Insights

Routine resale disclosure showing planned restricted‑share sales and a recent insider sale.

The excerpt lists restricted Common stock awards dated 03/15/2025 (4,249 and 1,145 shares) and 04/15/2025 (835 shares). It separately records a prior sale of 7,800 shares on 03/16/2026 for $1,184,437.02.

These items are typical Form 144 disclosures. Timing and distribution method for the proposed sales are not specified in the excerpt; subsequent filings or broker updates may provide execution details.

Form date 05/13/2026 Filed date shown in excerpt
Sale by Maciej Kurzymski 7,800 shares Sale dated 03/16/2026
Proceeds from sale $1,184,437.02 Proceeds reported for 7,800‑share sale on 03/16/2026
Restricted shares (1) 4,249 shares Restricted stock dated 03/15/2025
Restricted shares (2) 1,145 shares Restricted stock dated 03/15/2025
Restricted shares (3) 835 shares Restricted stock dated 04/15/2025
Restricted Stock financial
"Common | 03/15/2025 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Form 144 regulatory
"CONTENT METADATA: "form_type": "144""
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities To Be Sold regulatory
"144: Securities To Be Sold"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for BE disclose?

The Form 144 discloses planned resale of restricted Common shares dated 03/15/2025 and 04/15/2025, and a reported sale of 7,800 shares on 03/16/2026 for $1,184,437.02. It is a regulatory notice of proposed insider sales.

How many shares did Maciej Kurzymski sell according to this filing?

The filing reports a sale of 7,800 shares by Maciej Kurzymski on 03/16/2026. The disclosed cash consideration for that sale is $1,184,437.02 in the excerpt provided.

Which restricted stock grants are listed in the BE Form 144 excerpt?

The excerpt lists restricted Common stock entries dated 03/15/2025 of 4,249 and 1,145 shares, and an entry dated 04/15/2025 of 835 shares. These appear as award/issuer entries in the securities table.

Does the filing state when the proposed sales will occur?

The provided excerpt does not specify execution dates or sale mechanics for the proposed resales. The filing shows award dates and a prior sale date but does not detail timing or distribution methods for future sales.

What is the filing date shown in the excerpt for this Form 144?

The excerpt includes a date of 05/13/2026, which appears alongside exchange and security identifiers. This likely corresponds to the Form 144 submission date in the provided content.